Regeneron Pharmaceuticals (REGN) EBT Margin Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 49,756.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 441.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -408.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -408.00 |
| Dec 31, 2025 | -129,783.00 |
| Sep 30, 2025 | -445.00 |
| Jun 30, 2025 | 761.00 |
| Mar 31, 2025 | -209,232.00 |
| Dec 31, 2024 | -2,527.00 |
| Sep 30, 2024 | -1,249.00 |
| Jun 30, 2024 | -2,713.00 |
| Mar 31, 2024 | -2,727.00 |
| Dec 31, 2023 | -1,713.00 |
| Sep 30, 2023 | -1,048.00 |
| Jun 30, 2023 | -1,279.00 |
| Mar 31, 2023 | -944.00 |
| Dec 31, 2022 | 127,695.00 |
| Sep 30, 2022 | 735.00 |
| Jun 30, 2022 | 1,947.00 |
| Mar 31, 2022 | 208,241.00 |
| Dec 31, 2021 | 1,548.00 |
| Sep 30, 2021 | 1,439.00 |
| Jun 30, 2021 | 3,223.00 |